文献速递腹部MR

在LI-RADS 2018版中扩展应用减影动脉期成像:一种提高钆塞酸二钠增强MRI对肝细胞癌诊断性能的策略

Extended application of subtraction arterial phase imaging in LI-RADS version 2018: a strategy to improve the diagnostic performance for hepatocellular carcinoma on gadoxetate disodium-enhanced MRI.
PubMed 文献 · Eur Radiol · 2020-09-04

本回顾性研究纳入234例高危患者共311个观察灶(含239个肝细胞癌),比较减影动脉期成像仅用于T1高信号观察灶(传统APHE)与扩展用于T1高、等、低信号观察灶(改良APHE)对肝细胞癌的诊断性能;改良非环状APHE敏感度更高且特异度无显著差异。

要点

  • 减影动脉期成像扩展用于T1等/低信号观察灶可提高非环状APHE诊断肝细胞癌的敏感度(90.0% vs 82.8%)。
  • 改良非环状APHE不降低特异度(66.7% vs 68.1%,差异无统计学意义)。
  • 采用改良非环状APHE的LR-5类敏感度更高(70.3% vs 63.2%),特异度无显著下降(94.4% vs 95.8%)。

诊断标准与关键数值

  • 传统非环状APHE(减影动脉期成像仅用于T1高信号观察灶)诊断肝细胞癌敏感度82.8%、特异度68.1%。
  • 改良非环状APHE(减影动脉期成像用于T1高、等、低信号观察灶)诊断肝细胞癌敏感度90.0%、特异度66.7%,敏感度较传统方法提高(p < 0.001),特异度差异无统计学意义(p > 0.999)。
  • 采用传统非环状APHE的LR-5类诊断肝细胞癌敏感度63.2%、特异度95.8%。
  • 采用改良非环状APHE的LR-5类诊断肝细胞癌敏感度70.3%、特异度94.4%,敏感度较传统方法提高(p < 0.001),特异度差异无统计学意义(p > 0.999)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: This study aimed to assess the detection of hepatocellular carcinoma (HCC) utilizing subtraction AP (arterial phase) imaging only for T1 hyperintense observations compared with the detection of HCC on subtraction AP imaging that included T1 hyper-, iso-, and hypointense lesions on gadoxetate disodium-enhanced MRI.

MATERIALS AND METHODS: This retrospective study included 234 patients (311 observations including 239 HCCs) at high risk for HCC who underwent gadoxetate disodium-enhanced MRI with subtraction AP imaging between 2015 and 2017. Arterial phase hyperenhancement (APHE) was divided into two subtypes: conventional APHE, where subtraction AP imaging is used to detect APHE only for T1 hyperintense observations; and modified APHE, where subtraction AP imaging is applied to T1 hyper-, iso-, and hypointense lesions. Two readers independently reviewed all observations and the per-observation diagnostic performances were compared using McNemar's test.

RESULTS: Modified nonrim APHE showed significantly higher sensitivity than conventional nonrim APHE (90.0% vs 82.8%; p < 0.001) for diagnosing HCC, without a significant difference in specificity (66.7% vs 68.1%; p > 0.999). The LR-5 category with modified nonrim APHE provided better sensitivity than the LR-5 with conventional nonrim APHE (70.3% vs 63.2%; p < 0.001), without a significant decrease in specificity (94.4% vs 95.8%; p > 0.999).

CONCLUSION: Extended application of subtraction AP imaging for T1 hypo- or isointense observations on gadoxetate disodium-enhanced MRI can improve sensitivity in the diagnosis of HCC without a significant difference in specificity.

KEY POINTS: • Modified nonrim arterial phase hyperenhancement (APHE), extended application of subtraction arterial phase imaging for T1 hypo- or isointense observation, outperforms conventional nonrim APHE. • The LR-5 category with modified nonrim APHE provided better sensitivity in diagnosing HCC than the LR-5 with conventional APHE, without a significant decrease in specificity.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Kim SS, Lee S, Bae H, et al. Extended application of subtraction arterial phase imaging in LI-RADS version 2018: a strategy to improve the diagnostic performance for hepatocellular carcinoma on gadoxetate disodium-enhanced MRI. Eur Radiol. 2020. PMID: 32886205. doi:10.1007/s00330-020-07229-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。